Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $58.6B |
| FY2017, ended Dec 31, 2017 | $52.4B |
| FY2018, ended Dec 31, 2018 | $39.3B |
| FY2019, ended Dec 31, 2019 | $46.7B |
| FY2020, ended Dec 31, 2020 | $41.5B |
| FY2021, ended Dec 31, 2021 | $51.6B |
| FY2022, ended Dec 31, 2022 | $56.0B |
| FY2023, ended Dec 31, 2023 | $47.8B |
| FY2024, ended Dec 31, 2024 | $55.8B |
| FY2025, ended Dec 31, 2025 | $51.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $53.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $60.8B |
| FY2017, ended Dec 31, 2017 | $62.3B |
| FY2018, ended Dec 31, 2018 | $67.9B |
| FY2019, ended Dec 31, 2019 | $69.6B |
| FY2020, ended Dec 31, 2020 | $67.8B |
| FY2021, ended Dec 31, 2021 | $68.7B |
| FY2022, ended Dec 31, 2022 | $68.8B |
| FY2023, ended Dec 31, 2023 | $66.9B |
| FY2024, ended Dec 31, 2024 | $71.0B |
| FY2025, ended Dec 31, 2025 | $77.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $79.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $850M |
| FY2017, ended Dec 31, 2017 | $4.01B |
| FY2018, ended Dec 31, 2018 | $5.12B |
| FY2019, ended Dec 31, 2019 | $5.90B |
| FY2020, ended Dec 31, 2020 | $5.41B |
| FY2021, ended Dec 31, 2021 | $6.86B |
| FY2022, ended Dec 31, 2022 | $5.28B |
| FY2023, ended Dec 31, 2023 | $1.58B |
| FY2024, ended Dec 31, 2024 | $4.43B |
| FY2025, ended Dec 31, 2025 | $3.38B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.63B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $12.7B |
| FY2017, ended Dec 31, 2017 | $12.7B |
| FY2018, ended Dec 31, 2018 | $15.8B |
| FY2019, ended Dec 31, 2019 | $16.6B |
| FY2020, ended Dec 31, 2020 | $19.8B |
| FY2021, ended Dec 31, 2021 | $20.0B |
| FY2022, ended Dec 31, 2022 | $20.2B |
| FY2023, ended Dec 31, 2023 | $20.6B |
| FY2024, ended Dec 31, 2024 | $20.1B |
| FY2025, ended Dec 31, 2025 | $22.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $19.3B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.7B |
| FY2017, ended Dec 31, 2017 | $16.2B |
| FY2018, ended Dec 31, 2018 | $13.1B |
| FY2019, ended Dec 31, 2019 | $13.7B |
| FY2020, ended Dec 31, 2020 | $15.0B |
| FY2021, ended Dec 31, 2021 | $14.3B |
| FY2022, ended Dec 31, 2022 | $14.8B |
| FY2023, ended Dec 31, 2023 | $15.7B |
| FY2024, ended Dec 31, 2024 | $15.6B |
| FY2025, ended Dec 31, 2025 | $14.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 41.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.09B |
| FY2017, ended Dec 31, 2017 | 1.04B |
| FY2018, ended Dec 31, 2018 | 957M |
| FY2019, ended Dec 31, 2019 | 916M |
| FY2020, ended Dec 31, 2020 | 884M |
| FY2021, ended Dec 31, 2021 | 825M |
| FY2022, ended Dec 31, 2022 | 774M |
| FY2023, ended Dec 31, 2023 | 723M |
| FY2024, ended Dec 31, 2024 | 681M |
| FY2025, ended Dec 31, 2025 | 652M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 635M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $372M | $147M | $0 |
| FY2017, ended Dec 31, 2017 | $2.93B | $128M | — |
| FY2018, ended Dec 31, 2018 | $3.99B | $86.0M | — |
| FY2019, ended Dec 31, 2019 | $2.29B | $150M | — |
| FY2020, ended Dec 31, 2020 | $1.15B | $127M | — |
| FY2021, ended Dec 31, 2021 | $4.30B | $173M | — |
| FY2022, ended Dec 31, 2022 | $3.33B | $184M | — |
| FY2023, ended Dec 31, 2023 | $3.10B | $171M | — |
| FY2024, ended Dec 31, 2024 | $3.21B | $168M | — |
| FY2025, ended Dec 31, 2025 | $2.88B | $131M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.44B | — | — |
Valuation
At current price- Market Cap
- $63.5B
- P/E
- 17.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.8×
- Price / Book
- 2.3×
- EV / EBITDA
- 8.8×
Growth
Trailing 12 months- Revenue (TTM)
- $79.4B
- Revenue Growth YoY
- 8.7%
- Revenue CAGR 3Y
- 3.9%
- Revenue CAGR 5Y
- 2.6%
- EPS Growth YoY
- −11.4%
- Net Income Growth YoY
- −15.4%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 8.3%
- Net Margin
- 4.6%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 13.2%
Earnings
Trailing 12 months- Net Income
- $3.63B
- EPS (diluted)
- $5.22
- EBITDA
- $6.69B
- Operating Income
- $6.56B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $19.3B
- Total Debt
- $14.7B
- Net Cash
- $4.60B
- Total Assets
- $759B
- Total Liabilities
- $731B
- Shareholders' Equity
- $27.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $15.6B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.3%
- Dividend / Share
- $2.32
- Beta (5Y)
- 0.78
Every ratio is calculated from the company’s reported figures.